Hypertrophy of Rat Skeletal Muscle Is Associated with Increased SIRT1/Akt/mTOR/S6 and Suppressed Sestrin2/SIRT3/FOXO1 Levels.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Jul 2021
Historique:
received: 26 06 2021
revised: 12 07 2021
accepted: 13 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 18 8 2021
Statut: epublish

Résumé

Despite the intensive investigation of the molecular mechanism of skeletal muscle hypertrophy, the underlying signaling processes are not completely understood. Therefore, we used an overload model, in which the main synergist muscles (gastrocnemius, soleus) of the plantaris muscle were surgically removed, to cause a significant overload in the remaining plantaris muscle of 8-month-old Wistar male rats. SIRT1-associated pro-anabolic, pro-catabolic molecular signaling pathways, NAD and H

Identifiants

pubmed: 34299206
pii: ijms22147588
doi: 10.3390/ijms22147588
pmc: PMC8305659
pii:
doi:

Substances chimiques

Muscle Proteins 0
Nerve Tissue Proteins 0
Nuclear Proteins 0
SIRT3 protein, rat 0
Sesn2 protein, rat 0
Foxo1 protein, rat 0
mTOR protein, rat EC 2.7.1.1
Akt1 protein, rat EC 2.7.11.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
Ribosomal Protein S6 Kinases EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1
Sirt1 protein, rat EC 3.5.1.-
Sirtuin 1 EC 3.5.1.-
Sirtuins EC 3.5.1.-
Cystathionine beta-Synthase EC 4.2.1.22

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Innovation and Technology Ministry, Hungary
ID : TKP2020-NKA-26

Références

Physiology (Bethesda). 2019 Jul 1;34(4):232-239
pubmed: 31165685
Redox Biol. 2018 Oct;19:46-51
pubmed: 30107294
Oxid Med Cell Longev. 2019 Apr 7;2019:9752698
pubmed: 31089421
Gerontology. 2018;64(2):127-134
pubmed: 29190625
Physiol Rep. 2021 Mar;9(5):e14789
pubmed: 33660929
Toxicol Appl Pharmacol. 2013 Aug 15;271(1):95-105
pubmed: 23651738
Exp Gerontol. 2018 Sep;110:23-34
pubmed: 29751091
Development. 2016 Sep 1;143(17):3050-60
pubmed: 27578176
Acta Physiol (Oxf). 2013 May;208(1):57-65
pubmed: 23181439
Pharmacol Rev. 2017 Oct;69(4):497-564
pubmed: 28978633
F1000Res. 2019 Sep 11;8:
pubmed: 31559011
Arch Biochem Biophys. 2019 Feb 15;662:49-60
pubmed: 30452895
Lipids Health Dis. 2012 Feb 08;11:23
pubmed: 22316301
Cell Mol Life Sci. 2014 May;71(9):1657-71
pubmed: 24232446
Am J Physiol Cell Physiol. 2021 Apr 1;320(4):C591-C601
pubmed: 33471625
Cell Metab. 2013 Jan 8;17(1):73-84
pubmed: 23274085
Science. 2004 Apr 23;304(5670):596-600
pubmed: 15105503
Sports Med. 2014 Aug;44(8):1125-38
pubmed: 24696049
J Inherit Metab Dis. 2011 Feb;34(1):49-55
pubmed: 20821054
Sci Adv. 2020 Jan 01;6(1):eaax8358
pubmed: 31911946
Science. 2010 Mar 5;327(5970):1223-8
pubmed: 20203043
Oncotarget. 2018 Jun 5;9(43):27318
pubmed: 29930768
Science. 2004 Jul 16;305(5682):390-2
pubmed: 15205477
J Physiol. 2017 Jun 1;595(11):3361-3376
pubmed: 28251652
Nat Commun. 2020 Jan 13;11(1):190
pubmed: 31929512
Mol Cell Biol. 2013 Mar;33(6):1104-13
pubmed: 23297346
J Pharm Pharmacol. 2020 Mar;72(3):424-436
pubmed: 31846093
J Clin Med. 2020 Feb 09;9(2):
pubmed: 32050426
Antioxid Redox Signal. 2019 Jan 10;30(2):184-197
pubmed: 29343087
Front Physiol. 2020 Dec 03;11:608474
pubmed: 33343399
Nat Cell Biol. 2001 Nov;3(11):1014-9
pubmed: 11715023
Mediators Inflamm. 2018 Jul 5;2018:6209140
pubmed: 30116150
Int J Mol Sci. 2018 Oct 11;19(10):
pubmed: 30314396
J Biol Chem. 2013 Oct 18;288(42):30515-30526
pubmed: 24003218
Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1132-9
pubmed: 19176887
Free Radic Biol Med. 2013 May;58:87-97
pubmed: 23339850
Cell. 2008 Aug 8;134(3):451-60
pubmed: 18692468
Methods Enzymol. 2015;554:3-29
pubmed: 25725513
Adv Exp Med Biol. 2018;1088:109-137
pubmed: 30390250
Cell. 2015 Jan 15;160(1-2):132-44
pubmed: 25542313
Am J Physiol Endocrinol Metab. 2016 Sep 1;311(3):E594-604
pubmed: 27382036
FASEB J. 2018 Apr;32(4):1741-1777
pubmed: 29242278
Free Radic Biol Med. 2019 May 20;136:146-158
pubmed: 30970274

Auteurs

Zoltan Gombos (Z)

Research Center of Molecular Exercise Science, University of Physical Education, H-1123 Budapest, Hungary.

Erika Koltai (E)

Research Center of Molecular Exercise Science, University of Physical Education, H-1123 Budapest, Hungary.

Ferenc Torma (F)

Research Center of Molecular Exercise Science, University of Physical Education, H-1123 Budapest, Hungary.

Peter Bakonyi (P)

Research Center of Molecular Exercise Science, University of Physical Education, H-1123 Budapest, Hungary.

Attila Kolonics (A)

Research Center of Molecular Exercise Science, University of Physical Education, H-1123 Budapest, Hungary.

Dora Aczel (D)

Research Center of Molecular Exercise Science, University of Physical Education, H-1123 Budapest, Hungary.

Tamas Ditroi (T)

Department of Molecular Immunology and Toxicology, National Institute of Oncology, H-1122 Budapest, Hungary.

Peter Nagy (P)

Department of Molecular Immunology and Toxicology, National Institute of Oncology, H-1122 Budapest, Hungary.
Department of Anatomy and Histology, University of Veterinary Medicine, H-1078 Budapest, Hungary.

Takuji Kawamura (T)

Faculty of Sport Sciences, Waseda University, Tokorozawa 2-579-15, Japan.

Zsolt Radak (Z)

Research Center of Molecular Exercise Science, University of Physical Education, H-1123 Budapest, Hungary.
Faculty of Sport Sciences, Waseda University, Tokorozawa 2-579-15, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH